Amy Welsh
Corporate Officer/Principal bij AGILE THERAPEUTICS, INC.
Vermogen: 4 590 $ op 31-03-2024
Profiel
Amy Welsh is currently the Chief Commercial Officer at Agile Therapeutics, Inc. She previously worked as the Vice President-Marketing at Antares Pharma, Inc. from 2017 to 2020.
Ms. Welsh completed her undergraduate degree at LaSalle University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AGILE THERAPEUTICS, INC.
0.20% | 28-06-2023 | 13 500 ( 0.20% ) | 4 590 $ | 31-03-2024 |
Actieve functies van Amy Welsh
| Bedrijven | Functie | Begin |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2022 |
Eerdere bekende functies van Amy Welsh
| Bedrijven | Functie | Einde |
|---|---|---|
| ANTARES PHARMA, INC. | Sales & Marketing | 01-05-2020 |
Opleiding van Amy Welsh
| LaSalle University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
